AXS-12

Reboxetine · Axsome Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXS-12, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy [Phase 3]